195 related articles for article (PubMed ID: 31176796)
1. Long-term treatment with human immunoglobulin for antisynthetase syndrome-associated interstitial lung disease.
Huapaya JA; Hallowell R; Silhan L; Pinal-Fernandez I; Casal-Dominguez M; Johnson C; Albayda J; Paik JJ; Lin CT; Hussien A; Mammen AL; Christopher-Stine L; Danoff SK
Respir Med; 2019; 154():6-11. PubMed ID: 31176796
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Treatment With Azathioprine and Mycophenolate Mofetil for Myositis-Related Interstitial Lung Disease.
Huapaya JA; Silhan L; Pinal-Fernandez I; Casal-Dominguez M; Johnson C; Albayda J; Paik JJ; Sanyal A; Mammen AL; Christopher-Stine L; Danoff SK
Chest; 2019 Nov; 156(5):896-906. PubMed ID: 31238042
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporine in anti-Jo1-positive patients with corticosteroid-refractory interstitial lung disease.
Cavagna L; Caporali R; Abdì-Alì L; Dore R; Meloni F; Montecucco C
J Rheumatol; 2013 Apr; 40(4):484-92. PubMed ID: 23418387
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin therapy for refractory interstitial lung disease associated with polymyositis/dermatomyositis.
Suzuki Y; Hayakawa H; Miwa S; Shirai M; Fujii M; Gemma H; Suda T; Chida K
Lung; 2009; 187(3):201-6. PubMed ID: 19387736
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary Involvement in the Antisynthetase Syndrome: A Comparative Cross-sectional Study.
Andersson H; Aaløkken TM; Günther A; Mynarek GK; Garen T; Lund MB; Molberg Ø
J Rheumatol; 2016 Jun; 43(6):1107-13. PubMed ID: 27036381
[TBL] [Abstract][Full Text] [Related]
6. Clinical profiles and treatment outcomes of outpatients with interstitial lung disease and mechanic's hands: A retrospective and observational cohort.
Miranda GFM; Soares MR; Souza AWS; Andrade LEC; Pereira CAC
Medicine (Baltimore); 2024 Jun; 103(26):e38642. PubMed ID: 38941439
[TBL] [Abstract][Full Text] [Related]
7. Rituximab in the Treatment of Interstitial Lung Disease Associated with Antisynthetase Syndrome: A Multicenter Retrospective Case Review.
Doyle TJ; Dhillon N; Madan R; Cabral F; Fletcher EA; Koontz DC; Aggarwal R; Osorio JC; Rosas IO; Oddis CV; Dellaripa PF
J Rheumatol; 2018 Jun; 45(6):841-850. PubMed ID: 29606668
[TBL] [Abstract][Full Text] [Related]
8. Clinical Characteristics and Natural History of Autoimmune Forms of Interstitial Lung Disease: A Single-Center Experience.
Chartrand S; Lee JS; Swigris JJ; Stanchev L; Fischer A
Lung; 2019 Dec; 197(6):709-713. PubMed ID: 31583453
[TBL] [Abstract][Full Text] [Related]
9. Respiratory bronchiolitis-interstitial lung disease: long-term outcome.
Portnoy J; Veraldi KL; Schwarz MI; Cool CD; Curran-Everett D; Cherniack RM; King TE; Brown KK
Chest; 2007 Mar; 131(3):664-671. PubMed ID: 17356078
[TBL] [Abstract][Full Text] [Related]
10. Antisynthetase syndrome with refractory lung involvement and myositis successfully treated with double filtration plasmapheresis.
Bozkirli DE; Kozanoglu I; Bozkirli E; Yucel E
J Clin Apher; 2013 Dec; 28(6):422-5. PubMed ID: 23908096
[TBL] [Abstract][Full Text] [Related]
11. Intravenous cyclophosphamide pulse therapy in interstitial lung disease associated with systemic sclerosis in a retrospective open-label study: influence of the extent of inflammation on pulmonary function.
van den Hombergh WMT; Simons SO; Teesselink E; Knaapen-Hans HKA; van den Hoogen FHJ; Fransen J; Vonk MC
Clin Rheumatol; 2018 Oct; 37(10):2715-2722. PubMed ID: 29987427
[TBL] [Abstract][Full Text] [Related]
12. Calcineurin inhibitors in a cohort of patients with antisynthetase-associated interstitial lung disease.
Labirua-Iturburu A; Selva-O'Callaghan A; Martínez-Gómez X; Trallero-Araguás E; Labrador-Horrillo M; Vilardell-Tarrés M
Clin Exp Rheumatol; 2013; 31(3):436-9. PubMed ID: 23465087
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics of patients with anti-EJ antisynthetase syndrome associated interstitial lung disease and literature review.
Liu Y; Liu X; Xie M; Chen Z; He J; Wang Z; Dai J; Cai H
Respir Med; 2020; 165():105920. PubMed ID: 32174452
[TBL] [Abstract][Full Text] [Related]
14. Rituximab and Cyclophosphamide in Antisynthetase Syndrome-related Interstitial Lung Disease: An Observational Retrospective Study.
Langlois V; Gillibert A; Uzunhan Y; Chabi ML; Hachulla E; Landon-Cardinal O; Mariampillai K; Champtiaux N; Nunes H; Benveniste O; Hervier B
J Rheumatol; 2020 Nov; 47(11):1678-1686. PubMed ID: 32173654
[TBL] [Abstract][Full Text] [Related]
15. Interstitial lung disease in antisynthetase syndrome without clinical myositis.
Sundaragiri PR; Vallabhajosyula S; Kanaan JP
BMJ Case Rep; 2014 Apr; 2014():. PubMed ID: 24700049
[No Abstract] [Full Text] [Related]
16. Clinical manifestations and long-term outcome of anti-Jo1 antisynthetase patients in a large cohort of Spanish patients from the GEAS-IIM group.
Trallero-Araguás E; Grau-Junyent JM; Labirua-Iturburu A; García-Hernández FJ; Monteagudo-Jiménez M; Fraile-Rodriguez G; Les-Bujanda I; Rodriguez-Carballeira M; Sáez-Comet L; Selva-O'Callaghan A;
Semin Arthritis Rheum; 2016 Oct; 46(2):225-231. PubMed ID: 27139168
[TBL] [Abstract][Full Text] [Related]
17. Rituximab in autoimmune connective tissue disease-associated interstitial lung disease.
Sharp C; McCabe M; Dodds N; Edey A; Mayers L; Adamali H; Millar AB; Gunawardena H
Rheumatology (Oxford); 2016 Jul; 55(7):1318-24. PubMed ID: 27060110
[TBL] [Abstract][Full Text] [Related]
18. The long-term outcome of anti-Jo-1-positive inflammatory myopathies.
Späth M; Schröder M; Schlotter-Weigel B; Walter MC; Hautmann H; Leinsinger G; Pongratz D; Müller-Felber W
J Neurol; 2004 Jul; 251(7):859-64. PubMed ID: 15258790
[TBL] [Abstract][Full Text] [Related]
19. The ILD-GAP risk prediction model performs poorly in myositis-associated interstitial lung disease.
Brusca RM; Pinal-Fernandez I; Psoter K; Paik JJ; Albayda J; Mecoli C; Tiniakou E; Mammen AL; Christopher-Stine L; Danoff S; Johnson C
Respir Med; 2019 Apr; 150():63-65. PubMed ID: 30961952
[TBL] [Abstract][Full Text] [Related]
20. Long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease.
Andersson H; Sem M; Lund MB; Aaløkken TM; Günther A; Walle-Hansen R; Garen T; Molberg Ø
Rheumatology (Oxford); 2015 Aug; 54(8):1420-8. PubMed ID: 25740830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
